HACKENSACK, N.J., March 13 /PRNewswire-FirstCall/ -- DOV Pharmaceutical, Inc. announced today that Ms. Barbara Duncan, Chief Financial Officer, will present at the Citigroup Small- and Mid-Cap Global Conference on Wednesday, March 15, 2006. Her presentation is scheduled to begin at 3:45 p.m. PST at the Four Seasons at Mandalay Bay in Las Vegas. Ms. Duncan will discuss the development and commercialization strategy for DOV’s leading product candidates and data from the Company’s late stage clinical development programs. A Web cast of the presentation may be accessed through the DOV Pharmaceutical Web site at http://www.dovpharm.com and Ms. Duncan’s presentation will be archived and available on the Investor Relations section of DOV’s Web site after the conference for 90 days.
About DOV
DOV is a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, pain and depression. Our partner Neurocrine has filed two NDAs for the use of DOV’s compound indiplon for the treatment of insomnia.
DOV Pharmaceutical, Inc.
CONTACT: Keri P. Mattox, Director, Investor Relations and CorporateCommunications of DOV Pharmaceutical, Inc., +1-201-968-0980
Web site: http://www.dovpharm.com/
